Skip to main content
Erschienen in: Cancer Causes & Control 1/2007

01.02.2007 | Original Paper

An evaluation of spatial and multivariate covariance among childhood cancer histotypes in Texas (United States)

verfasst von: James A. Thompson, Susan E. Carozza, Li Zhu

Erschienen in: Cancer Causes & Control | Ausgabe 1/2007

Einloggen, um Zugang zu erhalten

Abstract

Background

Spatial modeling of rare diseases, such as childhood cancer, has been hampered by imprecise risk estimates. Recent developments in Bayesian hierarchical modeling include the ability to adjust a disease risk estimate to be fully conditional for covariance among neighboring locations and for covariance among multiple diseases within each location. This joint modeling approach is called Multivariate Intrinsic Conditional Autoregressive. The objective of this study was to evaluate the spatial and histotype covariance among childhood cancer histotypes, in Texas. Results will be valuable for selecting appropriate models to support more specific etiologic studies of environmental factors for childhood cancer.

Methods

County level standard morbidity ratios for 13 childhood cancer histotype groups were estimated using Multivariate Intrinsic Conditional Autoregressive modeling and the results compared to results from two reduced models. The two reduced models were the base model specified with zero spatial covariance and the base model specified with zero histotype covariance. The results were compared using the Deviance Information Criterion and Geographical Information System techniques were used to compare patterns of standard morbidity ratios.

Results

Including histotype covariance greatly improved the Deviance Information Criterion and including spatial covariance produced a moderate improvement. Parameter evaluation by GIS techniques showed that excluding histotype covariance resulted in marked shrinkage of the risk estimates.

Conclusions

Investigation of childhood cancer could benefit by incorporating histotype covariance into environmental modeling.
Literatur
1.
Zurück zum Zitat Short M, Carlin BP, Bushhouse S (2002) Using hierarchical spatial models for cancer control planning in Minnesota (United States). Cancer Causes Control 13:903–916PubMedCrossRef Short M, Carlin BP, Bushhouse S (2002) Using hierarchical spatial models for cancer control planning in Minnesota (United States). Cancer Causes Control 13:903–916PubMedCrossRef
2.
Zurück zum Zitat Lawson AB, Bohning D, Biggeri A, Lesaffre E, Viel JF (1999) Disease mapping and its uses. In: Lawson A, Biggeri A, Bohning D, Lesaffre E, Viel J-F, Bertollini R (eds) Disease mapping and risk assessment for public health. Wiley, New York, NY, pp 3–13 Lawson AB, Bohning D, Biggeri A, Lesaffre E, Viel JF (1999) Disease mapping and its uses. In: Lawson A, Biggeri A, Bohning D, Lesaffre E, Viel J-F, Bertollini R (eds) Disease mapping and risk assessment for public health. Wiley, New York, NY, pp 3–13
3.
Zurück zum Zitat Willis A, Krewski D, Jerrett M, Goldberg MS, Burnett RT (2003) Selection of ecologic covariates in the American Cancer Society Study. J Toxicol Environ Health A 66:1563–1589PubMedCrossRef Willis A, Krewski D, Jerrett M, Goldberg MS, Burnett RT (2003) Selection of ecologic covariates in the American Cancer Society Study. J Toxicol Environ Health A 66:1563–1589PubMedCrossRef
4.
Zurück zum Zitat Roux AVD (2004) The study of group-level factors in epidemiology: rethinking variables, study designs, and analytical approaches. Epidemiol Rev 26:104–111CrossRef Roux AVD (2004) The study of group-level factors in epidemiology: rethinking variables, study designs, and analytical approaches. Epidemiol Rev 26:104–111CrossRef
5.
Zurück zum Zitat Best N, Richardson S, Thomson A (2005) A comparison of Bayesian spatial models for disease mapping. Stat Methods Med Res 14:35–59PubMedCrossRef Best N, Richardson S, Thomson A (2005) A comparison of Bayesian spatial models for disease mapping. Stat Methods Med Res 14:35–59PubMedCrossRef
6.
Zurück zum Zitat Banerjee S, Carlin BP, Gelfand AE (2004) Overview of spatial data problems. Hierarchical modeling and analysis for spatial data. Chapman & Hall/CRC, Boca Raton, pp 1–20 Banerjee S, Carlin BP, Gelfand AE (2004) Overview of spatial data problems. Hierarchical modeling and analysis for spatial data. Chapman & Hall/CRC, Boca Raton, pp 1–20
7.
Zurück zum Zitat Spiegelhalter D, Thomas A, Best N, Lunn D (2003) WinBUGS user manual: Version 1.4. MRC Biostatistics Unit, Cambridge Spiegelhalter D, Thomas A, Best N, Lunn D (2003) WinBUGS user manual: Version 1.4. MRC Biostatistics Unit, Cambridge
8.
Zurück zum Zitat Carlin BP, Louis TA (2000) Bayes and empirical Bayes methods for data analysis. Chapman & Hall/CRC, New York Carlin BP, Louis TA (2000) Bayes and empirical Bayes methods for data analysis. Chapman & Hall/CRC, New York
9.
Zurück zum Zitat Besag J, York JC, Mollie A (1991) Bayesian image restoration, with two applications in spatial statistics (with discussion). Ann Inst Stat Math 43:1–59CrossRef Besag J, York JC, Mollie A (1991) Bayesian image restoration, with two applications in spatial statistics (with discussion). Ann Inst Stat Math 43:1–59CrossRef
10.
Zurück zum Zitat Assuncao RM, Castro MSM (2004) Multiple cancer sites incidence rates estimation using a multivariate Bayesian model. Int J Epidemiol 33:508–516PubMedCrossRef Assuncao RM, Castro MSM (2004) Multiple cancer sites incidence rates estimation using a multivariate Bayesian model. Int J Epidemiol 33:508–516PubMedCrossRef
11.
Zurück zum Zitat Kramarova E, Plesko I, Black RJ, Obsitnikova A (1996) Improving survival for childhood cancer in Slovakia. Int J Cancer 65:594–600PubMedCrossRef Kramarova E, Plesko I, Black RJ, Obsitnikova A (1996) Improving survival for childhood cancer in Slovakia. Int J Cancer 65:594–600PubMedCrossRef
12.
Zurück zum Zitat Thomas A, Best N, Lunn D (2003) GeoBUGS User Manual Version 1.2. MRC Biostatistics Unit, Cambridge Thomas A, Best N, Lunn D (2003) GeoBUGS User Manual Version 1.2. MRC Biostatistics Unit, Cambridge
13.
Zurück zum Zitat Spiegelhalter DJ, Best NG, Carlin BP, van der Linde A (2002) Bayesian measures of model complexity and fit (with discussion). J R Stat Soc B 64:1–34CrossRef Spiegelhalter DJ, Best NG, Carlin BP, van der Linde A (2002) Bayesian measures of model complexity and fit (with discussion). J R Stat Soc B 64:1–34CrossRef
14.
Zurück zum Zitat Reynolds P, Von Behren J, Gunier RB, Goldberg DE, Hertz A, Harnly ME (2002) Childhood cancer and agricultural pesticide use: an ecologic study in California. Environ Health Perspect 110:319–324PubMedCrossRef Reynolds P, Von Behren J, Gunier RB, Goldberg DE, Hertz A, Harnly ME (2002) Childhood cancer and agricultural pesticide use: an ecologic study in California. Environ Health Perspect 110:319–324PubMedCrossRef
15.
Zurück zum Zitat Reynolds P, Von Behren J, Gunier RB, Goldberg DE, Hertz A, Smith DF (2003) Childhood cancer incidence rates and hazardous air pollutants in California: an exploratory analysis. Environ Health Perspect 111:663–668PubMedCrossRef Reynolds P, Von Behren J, Gunier RB, Goldberg DE, Hertz A, Smith DF (2003) Childhood cancer incidence rates and hazardous air pollutants in California: an exploratory analysis. Environ Health Perspect 111:663–668PubMedCrossRef
16.
Zurück zum Zitat Reynolds P, Von Behren J, Gunier RB, Goldberg DE, Harnly M, Hertz A (2005) Agricultural pesticide use and childhood cancer in California. Epidemiology 16:93–100PubMedCrossRef Reynolds P, Von Behren J, Gunier RB, Goldberg DE, Harnly M, Hertz A (2005) Agricultural pesticide use and childhood cancer in California. Epidemiology 16:93–100PubMedCrossRef
17.
Zurück zum Zitat Reynolds P, Von Behren J, Gunier R, Goldberg DE, Hertz A (2005) Agricultural pesticides and lymphoproliferative childhood cancer in California. Scand J Work Environ Health 31:46–54PubMed Reynolds P, Von Behren J, Gunier R, Goldberg DE, Hertz A (2005) Agricultural pesticides and lymphoproliferative childhood cancer in California. Scand J Work Environ Health 31:46–54PubMed
18.
Zurück zum Zitat Morris RD, Munasinghe RL (1993) Aggregation of existing geographic regions to diminish spurious variability of disease rates. Stat Med 12:1915–1929PubMed Morris RD, Munasinghe RL (1993) Aggregation of existing geographic regions to diminish spurious variability of disease rates. Stat Med 12:1915–1929PubMed
19.
Zurück zum Zitat Knox EG (2005) Childhood cancers and atmospheric carcinogens. J Epidemiol Community Health 59:101–5PubMedCrossRef Knox EG (2005) Childhood cancers and atmospheric carcinogens. J Epidemiol Community Health 59:101–5PubMedCrossRef
20.
Zurück zum Zitat Maisonet M, Correa A, Misra D, Jaakkola JJK (2004) A review of the literature on the effects of ambient air pollution on fetal growth. Environ Res 95:106–15PubMedCrossRef Maisonet M, Correa A, Misra D, Jaakkola JJK (2004) A review of the literature on the effects of ambient air pollution on fetal growth. Environ Res 95:106–15PubMedCrossRef
21.
Zurück zum Zitat Sram RJ, Binkova BB, Dejmek J, Bobak M (2005) Ambient air pollution and pregnancy outcomes: a review of the literature. Environ Health Perspect 113:375–382PubMedCrossRef Sram RJ, Binkova BB, Dejmek J, Bobak M (2005) Ambient air pollution and pregnancy outcomes: a review of the literature. Environ Health Perspect 113:375–382PubMedCrossRef
22.
Zurück zum Zitat Buffler PA, Kwan ML, Reynolds P, Urayama KY (2005) Environmental and genetic risk factors for childhood leukemia aising the evidence. Cancer Invest 23:60–75PubMed Buffler PA, Kwan ML, Reynolds P, Urayama KY (2005) Environmental and genetic risk factors for childhood leukemia aising the evidence. Cancer Invest 23:60–75PubMed
Metadaten
Titel
An evaluation of spatial and multivariate covariance among childhood cancer histotypes in Texas (United States)
verfasst von
James A. Thompson
Susan E. Carozza
Li Zhu
Publikationsdatum
01.02.2007
Verlag
Kluwer Academic Publishers
Erschienen in
Cancer Causes & Control / Ausgabe 1/2007
Print ISSN: 0957-5243
Elektronische ISSN: 1573-7225
DOI
https://doi.org/10.1007/s10552-006-0085-8

Weitere Artikel der Ausgabe 1/2007

Cancer Causes & Control 1/2007 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.